Clinical trial
Preventing Preeclampsia Recurrence in High-Risk Pregnancies Using Vitamin D Therapy: A Randomized Controlled Trial
NCT07717931 is registered in ClinicalTrials.gov with CMH Multan Institute of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preventing Preeclampsia Recurrence in High-Risk Pregnancies Using Vitamin D Therapy: A Randomized Controlled Trial
- Lead sponsor
- CMH Multan Institute of Medical Sciences
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 1, 2025
- Completion date
- January 30, 2026
- Enrollment
- 146 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
preeclampsia